Over the last 7 days, the Australian market has dropped 1.7%, but it has risen by 10% over the past year, with earnings expected to grow by 12% per annum in the coming years. In this context, identifying stocks trading below their fair value can be a strategic move for investors looking to capitalize on potential growth opportunities.

Top 10 Undervalued Stocks Based On Cash Flows In Australia

Click here to see the full list of 47 stocks from our Undervalued ASX Stocks Based On Cash Flows screener.

We'll examine a selection from our screener results.

Charter Hall Group

Overview: Charter Hall Group (ASX:CHC) is one of Australia’s leading fully integrated property investment and funds management groups, with a market cap of A$7.47 billion.

Operations: Charter Hall's revenue segments include A$448.60 million from Funds Management, A$322.80 million from Property Investments, and A$73.30 million from Development Investments.

Estimated Discount To Fair Value: 46.6%

Charter Hall Group appears undervalued based on cash flows, trading at A$15.79 against a fair value estimate of A$29.58. Despite a recent net loss of A$222.1 million and declining revenue, earnings are forecast to grow 31.51% annually with expected profitability in three years. The company also announced FY25 earnings guidance for post-tax operating earnings per security of approximately 79 cents and distribution growth of 6%, indicating potential recovery and value appreciation ahead.

• The growth report we've compiled suggests that Charter Hall Group's future prospects could be on the up.
• Click to explore a detailed breakdown of our findings in Charter Hall Group's balance sheet health report.

Lynas Rare Earths

Overview: Lynas Rare Earths Limited, with a market cap of A$6.58 billion, is involved in the exploration, development, mining, extraction, and processing of rare earth minerals in Australia and Malaysia.

Operations: Revenue from rare earth operations for the company amounts to A$463.29 million.

Estimated Discount To Fair Value: 36.2%

Lynas Rare Earths appears undervalued based on cash flows, trading at A$7.04 against a fair value estimate of A$11.04. Despite a significant drop in sales and net income for FY 2024, with sales at A$463.29 million and net income at A$84.51 million, earnings are forecast to grow 42.91% annually over the next three years, outpacing the Australian market's growth rate of 12.1%.

• According our earnings growth report, there's an indication that Lynas Rare Earths might be ready to expand.
• Click here to discover the nuances of Lynas Rare Earths with our detailed financial health report.

PolyNovo

Overview: PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally with a market cap of A$1.71 billion.

Operations: The company's revenue from the development, manufacturing, and commercialization of the NovoSorb technology is A$103.23 million.

Estimated Discount To Fair Value: 19.6%

PolyNovo, trading at A$2.47, is considered undervalued with a fair value estimate of A$3.07. The company recently reported a significant revenue increase to A$104.76 million and net income of A$5.26 million for FY 2024, reversing a previous net loss. Earnings are forecast to grow at 37.6% annually over the next three years, outpacing the Australian market's growth rate of 12.1%, highlighting its strong cash flow potential despite being slightly below fair value estimates.

• Upon reviewing our latest growth report, PolyNovo's projected financial performance appears quite optimistic.
• Navigate through the intricacies of PolyNovo with our comprehensive financial health report here.

Next Steps

• Unlock more gems! Our Undervalued ASX Stocks Based On Cash Flows screener has unearthed 44 more companies for you to explore.Click here to unveil our expertly curated list of 47 Undervalued ASX Stocks Based On Cash Flows.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:CHC ASX:LYC and ASX:PNV.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com